select a format

Single User License
USD 125 INR 8099
Site License
USD 250 INR 16198
Corporate User License
USD 375 INR 24296

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Chugai Pharmaceutical Co Ltd (4519)-Financial and Strategic SWOT Analysis Review

Chugai Pharmaceutical Co Ltd (4519)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH28303FSA
  • |
  • Pages: 54
  • |
  • April 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Chugai Pharmaceutical Co Ltd (4519)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chugai Pharmaceutical Co Ltd (Chugai), a subsidiary of Hoffmann-La Roche Ltd focuses on the manufacturing, marketing, import and export of new pharmaceutical products. The company's product portfolio focuses on various therapeutic areas including cancer treatment; bone and joint diseases; renal diseases; transplant, immunology and infectious diseases and others. Chugai's products include Avastin, Herceptin, Rituxan, Xeloda, Neutrogin, Tarceva, and Kadcyla for cancer treatements; Actemra, Suvenyl, Alfarol, Edirol for in bone and joint diseases; and Epogin, Mircera, Oxarol for renal diseases. Under its transplant, immunological infectious diseases area it markets and distributes Pegasys, Copegus and CellCept. Other products offered by the company include Sigmart, Tamiflu and others. The company also markets its pharmaceutical products in overseas markets, such as the US, the UK, Germany, France, Taiwan, China and Korea. Chugai is headquartered at Chuo-ku in Tokyo, Japan.

Chugai Pharmaceutical Co Ltd Key Recent Developments

Apr 04,2017: A First Approach in the Japanese Pharmaceutical Industry Starting a Trial of a Drug Adherence Support App Using Multidisciplinary SNS for Outpatient Cancer Treatment

Mar 30,2017: Chugai-ASTAR Joint Development Project for Anti-Dengue Virus Antibody Selected as Grant Recipient by the GHIT Fund

Mar 23,2017: Chugai Selected as a "Nadeshiko Brand" for the Third Consecutive Year

Feb 01,2017: Chugai Pharmaceutical Announces Organizational and Personnel Changes

Jan 27,2017: Aiming to Provide Solutions that Meet Changes of Regional Healthcare Services

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Chugai Pharmaceutical Co Ltd-Key Facts 6

Chugai Pharmaceutical Co Ltd-Key Employees 7

Chugai Pharmaceutical Co Ltd-Key Employee Biographies 9

Chugai Pharmaceutical Co Ltd-Major Products and Services 10

Chugai Pharmaceutical Co Ltd-Pharmaceutical Pipeline Products Data 12

Chugai Pharmaceutical Co Ltd, Pipeline Products by Therapy Area 12

Chugai Pharmaceutical Co Ltd, Pipeline Products by Development Phase 12

Chugai Pharmaceutical Co Ltd-History 14

Chugai Pharmaceutical Co Ltd-Company Statement 21

Chugai Pharmaceutical Co Ltd-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Joint Venture 25

Section 2-Company Analysis 26

Chugai Pharmaceutical Co Ltd-Business Description 26

Chugai Pharmaceutical Co Ltd-Corporate Strategy 27

Chugai Pharmaceutical Co Ltd-SWOT Analysis 28

SWOT Analysis-Overview 28

Chugai Pharmaceutical Co Ltd-Strengths 28

Chugai Pharmaceutical Co Ltd-Weaknesses 30

Chugai Pharmaceutical Co Ltd-Opportunities 31

Chugai Pharmaceutical Co Ltd-Threats 32

Chugai Pharmaceutical Co Ltd-Key Competitors 33

Section 3-Company Financial Ratios 34

Financial Ratios-Capital Market Ratios 34

Financial Ratios-Annual Ratios 35

Performance Chart 37

Financial Performance 37

Financial Ratios-Interim Ratios 38

Financial Ratios-Ratio Charts 39

Section 4-Company's Lifesciences Financial Deals and Alliances 40

Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 40

Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 41

Chugai Pharmaceutical Co Ltd, Recent Deals Summary 42

Section 5-Company's Recent Developments 43

Apr 04, 2017: A First Approach in the Japanese Pharmaceutical Industry Starting a Trial of a Drug Adherence Support App Using Multidisciplinary SNS for Outpatient Cancer Treatment 43

Mar 30, 2017: Chugai-ASTAR Joint Development Project for Anti-Dengue Virus Antibody Selected as Grant Recipient by the GHIT Fund 44

Feb 01, 2017: Chugai Pharmaceutical Announces Organizational and Personnel Changes 45

Jan 27, 2017: Aiming to Provide Solutions that Meet Changes of Regional Healthcare Services 46

Jan 25, 2017: Chugai Pharmaceutical: Personnel Changes 47

Dec 09, 2016: Chugai Pharmaceutical: Personnel Changes 48

Jan 28, 2016: Chugai Pharmaceutical: Organizational and Personnel Changes 49

Section 6-Appendix 50

Methodology 50

Ratio Definitions 50

About GlobalData 54

Contact Us 54

Disclaimer 54

List of Figures

Chugai Pharmaceutical Co Ltd, Pipeline Products by Therapy Area 12

Chugai Pharmaceutical Co Ltd, Pipeline Products by Development Phase 12

Chugai Pharmaceutical Co Ltd, Performance Chart (2012-2016) 37

Chugai Pharmaceutical Co Ltd, Ratio Charts 39

Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 40

Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 41

List of Tables

Chugai Pharmaceutical Co Ltd, Key Facts 6

Chugai Pharmaceutical Co Ltd, Key Employees 7

Chugai Pharmaceutical Co Ltd, Key Employee Biographies 9

Chugai Pharmaceutical Co Ltd, Major Products and Services 10

Chugai Pharmaceutical Co Ltd, Number of Pipeline Products by Development Stage 13

Chugai Pharmaceutical Co Ltd, History 14

Chugai Pharmaceutical Co Ltd, Other Locations 23

Chugai Pharmaceutical Co Ltd, Subsidiaries 24

Chugai Pharmaceutical Co Ltd, Joint Venture 25

Chugai Pharmaceutical Co Ltd, Key Competitors 33

Chugai Pharmaceutical Co Ltd, Ratios based on current share price 34

Chugai Pharmaceutical Co Ltd, Annual Ratios 35

Chugai Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 36

Chugai Pharmaceutical Co Ltd, Interim Ratios 38

Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 40

Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 41

Chugai Pharmaceutical Co Ltd, Recent Deals Summary 42

Currency Codes 50

Capital Market Ratios 50

Equity Ratios 51

Profitability Ratios 51

Cost Ratios 52

Liquidity Ratios 52

Leverage Ratios 53

Efficiency Ratios 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Wakamoto Pharmaceutical Co Ltd, Towa Pharmaceutical Co Ltd, Torii Pharmaceutical Co Ltd, Tesaro Inc, Takeda Pharmaceutical Company Ltd, Sumitomo Dainippon Pharma Co Ltd, Shionogi & Co Ltd, Mitsubishi Tanabe Pharma Corp, Kyowa Hakko Kirin Co Ltd, Daiichi Sankyo Company Ltd


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com